Drug Search Results
More Filters [+]

C-spine

Alternative Names: c-spine
Latest Update: 2024-06-01
Latest Update Note: PubMed Publication

Product Description

Means of evaluating Injury of Cervical Spine and Cervical Spine Fractures (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01278511)

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: KU LEUVEN
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for C-spine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Fracture Dislocation

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTO 0769

N/A

Completed

Low Back Pain|Spinal Cord Injuries|Neck Pain

2018-04-30

2009142-01H

N/A

Completed

Spinal Cord Injuries|Spinal Fractures

2015-08-01

ACTRN12616001098426

N/A

Completed

Other

2015-04-16

MOP-86709

P4

Completed

Fracture Dislocation

2010-07-01

Recent News Events